Search results
Create the page "Arthritis Research UK" on this wiki! See also the search results found.
- ...presentatives from subsidiaries, industry organisations, banks, unions and research organisations make up the Supervisory Board. Each member has one vote.{{ref ...Foundation]] (DDS), the [[Ludwig Heilmeyer Society]], the [[Association of Research-based Pharmaceutical Companies]] (VFA) and the [[German Asia-Pacific Busine50 KB (7,192 words) - 20:24, 3 June 2013
- ...Portland House, Bressenden Place - also houses oil lobbyists [[Oil and Gas UK]]]] ...holding is held by Grayling's senior managers.<ref>[http://www.grayling.co.uk/modules/home_what.cfm website Grayling website]</ref>20 KB (2,471 words) - 16:36, 20 July 2016
- http://wck2.companieshouse.gov.uk/9cad5b826cc1f54f6e61174774a9322a/compdetails accessed 1 December 2007</ref> [http://www.whitehouseconsulting.co.uk/aboutus.aspx About us] accessed 1 December 2007 </ref>37 KB (4,488 words) - 08:44, 25 July 2016
- ...udden cardiac deaths" [http://www.msnbc.msn.com/id/6192603/] through their arthritis treatment Vioxx between its approval in 1999 and its withdrawal from the ma ...n 1917.<ref> Merck Pharmaceuticals UK [http://www.merck-pharmaceuticals.co.uk/ Welcome to Merck] Accessed 13th December 2007</ref>12 KB (1,658 words) - 11:14, 29 April 2016
- :In 2001, Pfizer has budgeted approximately $5 billion (£3,402 bn) for research and development - more than any other drug company in the world. However, t ...in Asia. Powers guided the company in a new direction with an emphasis on research and development.24 KB (3,261 words) - 14:30, 13 July 2016
- [[Pharmaceutical Research and Manufacturers of America]] (PhRMA) [[PhRMA]] represents America’s leading research-based pharmaceutical and biotechnology companies, which are devoted to ‘i35 KB (5,289 words) - 09:56, 13 July 2006
- ...s and Aquariums]]<ref>House of Commons [http://www.publications.parliament.uk/pa/cm/cmallparty/register/contents.htm Register Of All-Party Groups] [as at The following is a list from December 2003: (from [http://www.parliament.uk/documents/upload/apg1.pdf]):47 KB (5,638 words) - 13:13, 24 April 2012
- ...ists, the profits are justified due to the unusual nature of the business: research and development costs for new drugs require huge investments (sometimes upw ...t drug company profits, which are higher than all other industries, exceed research and development expenditures; and that drug companies provide lavish compen51 KB (7,869 words) - 21:25, 18 February 2007
- ...overy of profits it maintains IG Farben (Bayer) earned as a result of such research. ...teriologists and scientists who want to test Bayer products for antibiotic research to sign a document stating that they will inform Bayer AG in writing of tes75 KB (11,176 words) - 11:18, 24 August 2009
- ...aking and as Scotland gets additional devolution.'<ref>[http://www.plmr.co.uk/about/plmr-scotland PLMR Scotland], PLMR website, accessed September 2015</ ...iver results for clients in the education sector.'<ref>[http://www.plmr.co.uk/what-we-do/sectors/education-skills PMLR website], accessed August 2015</re16 KB (2,069 words) - 10:24, 8 August 2017
- *[[Blue Rubicon]] since June 2014.<ref> [http://www.appc.org.uk/members/register/register-profile/?company=Open%20Road/Blue%20Rubicon Regis *[[Stratagem - NI]]<ref> [http://www.appc.org.uk/members/register/register-profile/?company=Stratagem%20(NI)%20Ltd Register7 KB (884 words) - 13:56, 29 April 2016
- ...Limited]] and [[May and Baker Limited]].<ref>[http://www.sanofi-aventis.co.uk/live/gb/en/index.jsp Welcome to the sanofi-aventis group in the United Kin ...5 million upfront payment to Regeneron and will fund up to $475 million of research over the next five years.<ref>http://www.smartbrief.com/news/aaaa/industryB16 KB (2,212 words) - 15:53, 5 November 2014
- ...RICAN HOME PRODUCTS CHANGES NAME TO WYETH, REFLECTING EVOLUTION TO GLOBAL, RESEARCH-BASED PHARMACEUTICAL COMPANY] Accessed 6th February 2008</ref> The UK division of Wyeth is referred to as [[Wyeth UK]].18 KB (2,630 words) - 14:59, 13 July 2016
- == Address(es) in UK == === Offices outside UK ===2 KB (174 words) - 16:06, 18 November 2008
- ...and stroke.<ref> NHS Choices: Behind the Headlines [http://http://www.nhs.uk/news/2008/10October/Pages/Vioxxriskconfirmed.aspx Vioxx Risk Confirmed] Acc ...to exaggerate its benefits.’ <ref> Frith, M. [http://www.independent.co.uk/life-style/health-and-wellbeing/health-news/exposed-how-drugs-giant-pushed-6 KB (912 words) - 14:36, 14 January 2010
- '''MHP Communications''' is one of the UK's largest PR and lobbying companies. ...control of MHPs clients with a Brussels interests and will use MHP for its UK and London-based activities.<ref> John Harrington [http://www.prweek.com/ar132 KB (14,291 words) - 14:41, 3 March 2017
- ...by [[GlaxoSmithKline]] (GSK)<ref>Stephen Foley, [http://www.independent.co.uk/news/business/news/gsk-insists-mmr-jab-is-safe-as-profits-rise-660773.html ...=”struck-off”> James Meikle and Sarah Boseley, [http://www.guardian.co.uk/society/2010/may/24/mmr-doctor-andrew-wakefield-struck-off MMR row doctor A54 KB (8,211 words) - 13:44, 1 October 2017
- ...of the [[Healthcare Communications Association]].<ref>[http://www.e-update.uk.com/rdc/about/history.php Red Door Communications] Accessed 2 May 2009</ref [[Red Door Communications]] concentrates on <ref>[http://www.e-update.uk.com/rdc/index.php Red Door Communications] accessed on 3 May 2009</ref>:2 KB (236 words) - 13:21, 4 May 2009
- === in UK=== ===Offices outside UK===2 KB (193 words) - 17:57, 19 October 2009
- ...iculture and Science in Parliament and Biologist.<ref>[http://www.oibc.org.uk/director.html Director: Prof Alan Malcolm], Oxford International Biomedical Malcolm has defended GM foods against the research findings of Dr [[Arpad Pusztai]] and the [[MMR]] vaccine against the findin6 KB (1,008 words) - 17:24, 4 February 2010
